(Q28477644)

English

Strategies and practices in off-label marketing of pharmaceuticals: a retrospective analysis of whistleblower complaints

scientific article

In more languages

edit

Statements

instance of

scholarly article

0 references

title

Strategies and practices in off-label marketing of pharmaceuticals: a retrospective analysis of whistleblower complaints (English)

0 references

1

Aaron S Kesselheim

0 references

David M Studdert

series ordinal

3

object named as

David M Studdert

0 references

Michelle M Mello

series ordinal

2

object named as

Michelle M Mello

0 references

language of work or name

English

0 references

publication date

April 2011

0 references

published in

PLOS MEDICINE

0 references

volume

8

0 references

issue

4

0 references

page(s)

e1000431

0 references

cites work

Off-label promotion, on-target sales

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3071370

retrieved

19 March 2017

Guest authorship and ghostwriting in publications related to rofecoxib: a case study of industry documents from rofecoxib litigation

2 references

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3071370

19 March 2017

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3071370

retrieved

6 April 2017

Following the script: how drug reps make friends and influence doctors

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3071370

retrieved

19 March 2017

Characteristics and impact of drug detailing for gabapentin

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3071370

retrieved

19 March 2017

The promotion of olanzapine in primary care: an examination of internal industry documents

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3071370

retrieved

29 September 2017

Shifting terrain in the regulation of off-label promotion of pharmaceuticals

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3071370

retrieved

29 September 2017

The ADVANTAGE seeding trial: a review of internal documents

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3071370

retrieved

29 September 2017

Narrative review: the promotion of gabapentin: an analysis of internal industry documents

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3071370

retrieved

29 September 2017

Safeguarding patient welfare: who's in charge?

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1371%2FJOURNAL.PMED.1000431

retrieved

21 January 2018

Whistleblower-initiated enforcement actions against health care fraud and abuse in the United States, 1996 to 2005.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1371%2FJOURNAL.PMED.1000431

retrieved

21 January 2018

Whistle-blowers' experiences in fraud litigation against pharmaceutical companies

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1371%2FJOURNAL.PMED.1000431

retrieved

21 January 2018

Toward More Uniform Conflict Disclosures — The Updated ICMJE Conflict of Interest Reporting Form

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1371%2FJOURNAL.PMED.1000431

retrieved

21 January 2018

Stanford to ban drug makers' gifts to doctors, even pens.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3071370

retrieved

27 November 2018

Pharmaceutical promotion to physicians and First Amendment rights

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21483716

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

FDA guidance on off-label promotion and the state of the literature from sponsors

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21483716

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1371/JOURNAL.PMED.1000431

0 references

PMC publication ID

3071370

0 references

PubMed publication ID

21483716

0 references

ResearchGate publication ID

51042480

0 references

(Q28477644)

Strategies and practices in off-label marketing of pharmaceuticals: a retrospective analysis of whistleblower complaints

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)